{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T19:22:34Z","timestamp":1783624954709,"version":"3.55.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010438","name":"Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu","doi-asserted-by":"publisher","award":["502-01-02228370-10617"],"award-info":[{"award-number":["502-01-02228370-10617"]}],"id":[{"id":"10.13039\/501100010438","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.vph.2018.12.005","type":"journal-article","created":{"date-parts":[[2018,12,24]],"date-time":"2018-12-24T12:07:56Z","timestamp":1545653276000},"page":"77-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["The endothelial status reflected by circulating endothelial cells, circulating endothelial progenitor cells and soluble thrombomodulin in patients with mild and resistant hypertension"],"prefix":"10.1016","volume":"113","author":[{"given":"Magdalena","family":"Budzy\u0144","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogna","family":"Gryszczy\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Boruczkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6282-3251","authenticated-orcid":false,"given":"Mariusz","family":"Kaczmarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Begier-Krasi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Osi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicja","family":"Bukowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Iskra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena Paulina","family":"Kasprzak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2018.12.005_bb0005","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1001\/jama.289.18.2363","article-title":"Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States","volume":"289","author":"Wolf-Maier","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.vph.2018.12.005_bb0010","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.vph.2018.12.005_bb0015","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.vph.2018.12.005_bb0020","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJM199601043340103","article-title":"Blood pressure and end-stage renal disease in men","volume":"334","author":"Klag","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2018.12.005_bb0025","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/hr.2013.30","article-title":"Resistant hypertension and target organ damage","volume":"36","author":"Muiesan","year":"2013","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.vph.2018.12.005_bb0030","first-page":"308","article-title":"Clinical characteristics, target organ damage and associate risk factors of resistant hypertension determined by ambulatory blood pressure monitoring in patients aged \u2265 80 years","volume":"14","author":"Zhi-Ru","year":"2017","journal-title":"J. Geriatr. Cardiol."},{"key":"10.1016\/j.vph.2018.12.005_bb0035","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/HJH.0000000000001167","article-title":"Carotid and aortic stiffness in essential hypertension and their relation with target organ damage: tha CATOD study","volume":"35","author":"Bruno","year":"2017","journal-title":"J. Hypertens."},{"key":"10.1016\/j.vph.2018.12.005_bb0040","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.2174\/138161206776843368","article-title":"Target Organ damage in hypertension: pathophysiology and implications for drug therapy","volume":"12","author":"Nadar","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.vph.2018.12.005_bb0045","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.cardiores.2004.12.021","article-title":"Hypertensive target organ damage is attenuated by a p38 MAPK inhibitor: role of systemic blood pressure and endothelial protection","volume":"66","author":"Olzinski","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.vph.2018.12.005_bb0050","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/jhh.2009.10","article-title":"Impaired endothelial function in hypertensive patients with target organ damage","volume":"23","author":"Xu","year":"2009","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.vph.2018.12.005_bb0055","doi-asserted-by":"crossref","first-page":"78","DOI":"10.12659\/MSM.889659","article-title":"The association between endothelial dysfunction and hypertensive retinopathy in essential hypertension","volume":"20","author":"Karaca","year":"2014","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.vph.2018.12.005_bb0060","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cca.2014.03.009","article-title":"Plasma 8-isoprostane levels are associated with endothelial dysfunction in resistant hypertension","volume":"433","author":"de Faria","year":"2014","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.vph.2018.12.005_bb0065","doi-asserted-by":"crossref","DOI":"10.1093\/ajh\/hpw082","article-title":"Associations between inflammation and endothelial dysfunction in resistant hypertension","volume":"29","author":"Tsuda","year":"2016","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.vph.2018.12.005_bb0070","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/5584_2016_90","article-title":"Endothelial Dysfunction and Hypertension","volume":"956","author":"Konukoglu","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.vph.2018.12.005_bb0075","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.2147\/CIA.S68544","article-title":"Relationship between resistant hypertension and arterial stiffness assessed by brachial-ankle pulse wave velocity in the older patient","volume":"9","author":"Chang-Min","year":"2014","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.vph.2018.12.005_bb0080","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2174\/157016112798829823","article-title":"Hypertension and endothelial dysfunction: therapeutic approach","volume":"10","author":"Ghiadoni","year":"2012","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.vph.2018.12.005_bb0085","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1161\/01.CIR.104.2.191","article-title":"Prognostic significance of endothelial dysfunction in hypertensive patients","volume":"104","author":"Perticone","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2018.12.005_bb0090","doi-asserted-by":"crossref","first-page":"w13122","DOI":"10.4414\/smw.2010.13122","article-title":"Three decades of endothelium research: from the detection of nitric oxide to the everyday implementation of endothelial function measurements in cardiovascular diseases","volume":"140","author":"Flammer","year":"2010","journal-title":"Swiss Med. Wkly."},{"key":"10.1016\/j.vph.2018.12.005_bb0095","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1161\/CIRCULATIONAHA.112.093245","article-title":"The assessment of endothelial function \u2013 from research into clinical practice","volume":"126","author":"Flammer","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2018.12.005_bb0100","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1161\/01.CIR.0000089191.72957.ED","article-title":"Endothelial function testing as a biomarker of vascular disease","volume":"108","author":"Verma","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2018.12.005_bb0105","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1046\/j.1365-2567.2002.01469.x","article-title":"Kinetics of thrombomodulin release and endothelial cell injury by neutrophil-derived proteases and oxygen radicals","volume":"107","author":"Boehme","year":"2002","journal-title":"Immunology"},{"key":"10.1016\/j.vph.2018.12.005_bb0110","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1182\/blood.V76.10.2024.2024","article-title":"Plasma thrombomodulin in health and diseases","volume":"76","author":"Takano","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.vph.2018.12.005_bb0115","first-page":"59","article-title":"Clinical importance of thrombomodulin serum levels","volume":"4","author":"Califano","year":"2000","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.vph.2018.12.005_bb0120","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1378\/chest.07-0428","article-title":"Circulating endothelial cells, arterial stiffness, and cardiovascular risk stratification in hypertension","volume":"132","author":"Boos","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.vph.2018.12.005_bb0125","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1056\/NEJMoa043814","article-title":"Circulating endothelial progenitor cells and cardiovascular outcomes","volume":"353","author":"Werner","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2018.12.005_bb0130","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1161\/CIRCULATIONAHA.104.504340","article-title":"Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair","volume":"111","author":"Schmidt-Lucke","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2018.12.005_bb0135","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1582-4934.2008.00639.x","article-title":"Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competence","volume":"13","author":"Sabatier","year":"2009","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.vph.2018.12.005_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1423-0410.2005.00589.x","article-title":"Circulating endothelial (progenitor) cells reflect the state of the endothelium: vascular injury, repair and neovascularization","volume":"88","author":"Hunting","year":"2005","journal-title":"Vox Sang."},{"key":"10.1016\/j.vph.2018.12.005_bb0145","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1172\/JCI8774","article-title":"Circulating endothelial precursors: mystery, reality, and promise","volume":"105","author":"Rafii","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.vph.2018.12.005_bb0150","doi-asserted-by":"crossref","first-page":"355","DOI":"10.4252\/wjsc.v6.i3.355","article-title":"Endothelial progenitor cells in cardiovascular diseases","volume":"6","author":"Lee","year":"2014","journal-title":"World J. Stem Cells"},{"key":"10.1016\/j.vph.2018.12.005_bb0155","doi-asserted-by":"crossref","DOI":"10.1111\/aji.12625","article-title":"Circulating endothelial cells, circulating endothelial progenitor cells, and von Willebrand factor in pregnancies complicated by hypertensive disorders","volume":"77","author":"Szpera-Go\u017adziewicz","year":"2017","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.vph.2018.12.005_bb0160","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00392-010-0277-9","article-title":"Endothelial dysfunction in hypertension in pregnancy: associations between circulating endothelial cells, circulating progenitor cells and plasma von Willebrand factor","volume":"100","author":"Karthikeyan","year":"2011","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.vph.2018.12.005_bb0165","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s11906-010-0150-2","article-title":"Vascular endothelial function and hypertension: insights and directions","volume":"12","author":"Dharmashankar","year":"2010","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.vph.2018.12.005_bb0170","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/jch.12546","article-title":"Endothelial function in hypertension: victim or culprit?","volume":"17","author":"Bleakley","year":"2015","journal-title":"J. Clin. Hypertens. (Greenwich)"},{"key":"10.1016\/j.vph.2018.12.005_bb0175","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11906-015-0596-3","article-title":"Clinical significance of endothelial dysfunction in essential hypertension","volume":"17","author":"Gkaliagkousi","year":"2015","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.vph.2018.12.005_bb0180","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1161\/01.CIR.0000112565.60887.1E","article-title":"Clinical correlates and heritability of flow-mediated dilation in the community: the Framingham Heart Study","volume":"109","author":"Benjamin","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2018.12.005_bb0185","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2143\/AC.55.4.2005744","article-title":"Endothelial dysfunction in hypertension","volume":"55","author":"Puddu","year":"2000","journal-title":"Acta Cardiol."},{"issue":"14","key":"10.1016\/j.vph.2018.12.005_bb0190","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1038\/sj.jhh.1000982","article-title":"Endothelial dysfunction in arterial hypertension","volume":"200","author":"Contreras","year":"2000","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.vph.2018.12.005_bb0195","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1097\/00004872-200111000-00018","article-title":"High prevalence of cardiac and extracardiac target organ damage in refractory hypertension","volume":"19","author":"Cuspidi","year":"2001","journal-title":"J. Hypertens."},{"key":"10.1016\/j.vph.2018.12.005_bb0200","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/cvr\/cvq119","article-title":"Cell-based methods for ex vivo evaluation of human endothelial biology","volume":"87","author":"Fadini","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.vph.2018.12.005_bb0205","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/j.1538-7836.2008.02918.x","article-title":"Circulating endothelial cells: from bench to clinical practice","volume":"6","author":"Shantsila","year":"2008","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.vph.2018.12.005_bb0210","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.tcm.2015.01.013","article-title":"Circulating endothelial cells in coronary artery disease and acute coronary syndrome","volume":"25","author":"Schmidt","year":"2015","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.vph.2018.12.005_bb0215","article-title":"Characterization of circulating endothelial cells in acute myocardial infarction","volume":"4","author":"Damani","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.vph.2018.12.005_bb0220","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.jstrokecerebrovasdis.2010.11.003","article-title":"Circulating endothelial cells and stroke: influence of stroke subtypes and changes during the course of disease","volume":"21","author":"Woywodt","year":"2012","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.vph.2018.12.005_bb0225","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1182\/blood-2003-09-3198","article-title":"Endothelial cell apoptosis in systemic lupus erythematosus: a common pathway for abnormal vascular function and thrombosis propensity","volume":"103","author":"Rajagopalan","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.vph.2018.12.005_bb0230","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ehj.2003.04.001","article-title":"Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells","volume":"25","author":"Makin","year":"2004","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.vph.2018.12.005_bb0235","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1160\/TH08-02-0122","article-title":"Correlation between circulating endothelial cell counts and plasma thrombomodulin levels as markers for endothelial damage","volume":"100","author":"Strijbos","year":"2008","journal-title":"Thromb. Haemost."},{"issue":"1_supplement","key":"10.1016\/j.vph.2018.12.005_bb0240","article-title":"Endothelial damage reflected by circulating endothelial cells in young patients with latent or manifest hypertension","volume":"25","author":"Lyamina","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.vph.2018.12.005_bb0245","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0272-6386(03)00906-5","article-title":"Circulating endothelial cells as potential markers of the state of the endothelium in hemodialysis patients","volume":"42","author":"Koc","year":"2003","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.vph.2018.12.005_bb0250","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1160\/TH04-12-0795","article-title":"Circulating endothelial cells in acute ischemic stroke","volume":"94","author":"Nadar","year":"2005","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.vph.2018.12.005_bb0255","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/jch.12287","article-title":"Circulating endothelial progenitor cells in hypertensive patients with increased arterial stiffness","volume":"16","author":"Marketou","year":"2014","journal-title":"J. Clin. Hypertens (Greenwich)"},{"key":"10.1016\/j.vph.2018.12.005_bb0260","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/HJH.0b013e3280109271","article-title":"Endothelial progenitor cells in patients with essential hypertension","volume":"25","author":"Delva","year":"2007","journal-title":"J. Hypertens."},{"key":"10.1016\/j.vph.2018.12.005_bb0265","doi-asserted-by":"crossref","first-page":"S471","DOI":"10.1097\/00005344-199100177-00135","article-title":"Plasma immunoreactive endothelin, but not thrombomodulin, is increased in patients with essential hypertension and ischemic heart disease","volume":"17","author":"Naruse","year":"1991","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.vph.2018.12.005_bb0270","first-page":"483","article-title":"Hemostatic disorders associated with arterial hypertension and peripheral arterial disease","volume":"36","author":"Trifiletti","year":"1995","journal-title":"J. Cardiovasc. Surg."},{"key":"10.1016\/j.vph.2018.12.005_bb0275","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0953-6205(00)00066-2","article-title":"Thrombomodulin as a marker of endothelium damage in some clinical conditions","volume":"11","author":"Remkov\u00e1","year":"2000","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.vph.2018.12.005_bb0280","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1161\/01.CIR.102.22.2720","article-title":"Increased plasma P-selectin and decreased thrombomodulin in pulmonary arterial hypertension were improved by continuous prostacyclin therapy","volume":"102","author":"Sakamaki","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2018.12.005_bb0285","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1378\/chest.124.4.1305","article-title":"Increase in thrombomodulin concentrations after pulmonary thromboendarterectomy in chronic thromboembolic pulmonary hypertension","volume":"124","author":"Sakamaki","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.vph.2018.12.005_bb0290","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1291\/hypres.26.479","article-title":"Circulating thrombomodulin levels are related to latent progression of atherosclerosis in hypertensive patients","volume":"26","author":"Dohi","year":"2003","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.vph.2018.12.005_bb0295","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1146\/annurev.med.51.1.149","article-title":"Atherogenic lipids and endothelial dysfunction: mechanisms in the genesis of ischemic syndromes","volume":"51","author":"Adams","year":"2000","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.vph.2018.12.005_bb0300","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0008-6363(99)00150-9","article-title":"Lipids and the endothelium","volume":"43","author":"Dart","year":"1999","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.vph.2018.12.005_bb0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11745-002-0858-6","article-title":"Lipids and endothelium-dependent vasodilation- a review","volume":"37","author":"Lind","year":"2002","journal-title":"Lipids"},{"key":"10.1016\/j.vph.2018.12.005_bb0310","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11883-013-0365-1","article-title":"Lipids and the endothelium: bidirectional interactions","volume":"15","author":"Goldberg","year":"2013","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.vph.2018.12.005_bb0315","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2015-000342","article-title":"The relationship between oxidised LDL, endothelial progenitor cells and coronary e endothelial function in patients with CHD","volume":"3","author":"Watt","year":"2016","journal-title":"Open Heart"},{"key":"10.1016\/j.vph.2018.12.005_bb0320","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1161\/01.CIR.0000015126.83143.B4","article-title":"Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein","volume":"105","author":"Verma","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2018.12.005_bb0325","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1161\/01.HYP.0000185463.27209.b0","article-title":"Arterial stiffness is related to systemic inflammation in essential hypertension","volume":"46","author":"Mahmud","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2018.12.005_bb0330","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1373\/clinchem.2011.169839","article-title":"C-reactive protein induces release of both endothelial microparticles and circulating endothelial cells in vitro and in vivo: further evidence of endothelial dysfunction","volume":"57","author":"Devaraj","year":"2011","journal-title":"Clin. Chem."},{"key":"10.1016\/j.vph.2018.12.005_bb0335","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ijcard.2005.10.014","article-title":"Inter-relationships of indices of endothelial damage\/dysfunction [circulating endothelial cells, von Willebrand factor and flow-mediated dilatation] to tissue factor and interleukin-6 in acute coronary syndromes","volume":"111","author":"Lee","year":"2006","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.vph.2018.12.005_bb0340","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1161\/01.CIR.0000143073.60937.50","article-title":"Endothelial dysfunction and damage in congestive heart failure: relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide","volume":"110","author":"Chong","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2018.12.005_bb0345","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1080\/08037050802584446","article-title":"Putative endothelial progenitor cells are associated with flow-mediated dilation in refractory hypertensives","volume":"17","author":"Oliveras","year":"2008","journal-title":"Blood Press."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189118302945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189118302945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T01:18:05Z","timestamp":1761527885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189118302945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":69,"alternative-id":["S1537189118302945"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2018.12.005","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The endothelial status reflected by circulating endothelial cells, circulating endothelial progenitor cells and soluble thrombomodulin in patients with mild and resistant hypertension","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2018.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}